A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty

Clinical trial NCT00269893 · COMPLETED

Trial details

NCT number: NCT00269893
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Angina, Unstable Angioplasty, Transluminal, Percutaneous Coronary

Start date: 1991-11-01
Primary completion: 1992-11-01
Enrollment: 2038

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.